PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 104 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $121,000 | -65.2% | 30,340 | -55.3% | 0.01% | -68.2% |
| Q4 2018 | $348,000 | -63.4% | 67,918 | -7.1% | 0.02% | -42.1% |
| Q1 2018 | $950,000 | +220.9% | 73,137 | +342.3% | 0.04% | +192.3% |
| Q4 2017 | $296,000 | -18.7% | 16,537 | +13.8% | 0.01% | -31.6% |
| Q3 2017 | $364,000 | +19.3% | 14,537 | +22.4% | 0.02% | +90.0% |
| Q2 2015 | $305,000 | +52.5% | 11,872 | +128.7% | 0.01% | +42.9% |
| Q4 2014 | $200,000 | – | 5,191 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,138,872 | $55,119,000 | 27.83% |
| Abingworth LLP | 1,301,413 | $33,524,000 | 15.22% |
| Roumell Asset Management, LLC | 207,703 | $5,353,000 | 9.43% |
| GREAT POINT PARTNERS LLC | 415,338 | $10,703,000 | 4.17% |
| Aisling Capital LLC | 682,680 | $17,593,000 | 2.62% |
| Broadfin Capital, LLC | 530,283 | $13,665,000 | 0.73% |
| Baupost Group | 1,544,498 | $39,802,000 | 0.66% |
| Tekla Capital Management LLC | 691,000 | $17,807,000 | 0.64% |
| GENERAL AMERICAN INVESTORS CO INC | 277,076 | $7,140,000 | 0.59% |
| Lombard Odier Asset Management (USA) Corp | 140,000 | $3,607,000 | 0.26% |